Colorectal mucin histochemistry in health and disease: A critical review

Pathology International

Volumn 44, Issue 7, 1994, Pages 487-504

  Jass, Jeremy R ^a   Roberton, Anthony M ^b  

^a School of Medicine New Zealand ^*  (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

blood group; colorectum; glycoprotein; immuno histochemistry; lectin; mucin

Indexed keywords

BLOOD GROUP ANTIGEN; MUCIN;

COLON CARCINOMA; COLON DISEASE; COLON POLYP; CONTROLLED STUDY; HISTOCHEMISTRY; HUMAN; HUMAN TISSUE; METAPLASIA; PRIORITY JOURNAL; REVIEW;

EID: 0028298263     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/j.1440-1827.1994.tb02599.x     Document Type: Article

References (143)

1. Molecular cloning of human intestinal mucin cDNAs. Sequence analysis and evidence for genetic polymorphism
2. Molecular cloning of cDNAs derived from a novel human intestinal mucin gene
3. A comparative ultrastructural study of hyperplastic and adenomatous polyps, incidental and in association with colorectal cancer
4. A morphologic and histochemical study of metaplastic polyps of the colorectum
5. Mucin‐type glycoproteins
6. Oligosaccharide structures of human colonic mucin
7. Oligosaccharide structures of isolated human colonic mucin species
8. Isolation and characterization of oligosaccharides from rat colonic mucus glycoprotein
9. Isolation and structural studies of sul‐phated glycoproteins of hog gastric mucosa
10. 2 into rat gastric mucosa
11. Structure determination of five sulfated oligosaccharides derived from tracheobronchial mucus glycoproteins
12. Sulfated sialo‐oligosaccharides derived from tracheobronchial mucous glycoproteins of a patient suffering from cystic fibrosis
13. Structures of O‐glycosidically linked oligosaccharides isolated from human meconium glycoproteins
14. Structure of two sulphated oligosaccharides from respiratory mucins of a patient suffering from cystic fibrosis
15. Isolation and characterisation of oligosaccharides from canine submaxillary mucin
16. Mucins in the human gastrointestinal epithelium: a review
17. Diamine methods for differentiating mucosubstances histochemically
18. The histochemical demonstration of O‐acylated sialic acid in gastrointestinal mucins. Their association with the potassium hydroxide‐periodic acid‐Schiff effect
19. Differences between the O‐acetylated sialic acids of the epithelial mucins of human colonic tumours and normal controls: A correlative chemical and histochemical study
20. Histochemical identification of side chain substituted O‐ acylated sialic acids: The PAT‐KOH‐Bh‐PASand the PAPT‐KOH‐Bh‐ PAS procedures
21. Chemical and histochemical studies of normal and diseased human gastrointestinal tract. III. Changes in the histochemical and chemical properties of the epithelial glycoproteins in the mucosa close to colonic tumours
22. Chemical and histochemical studies of normal and diseased human gastrointestinal tract. V. A differential diagnostic method for the histochemical classification of glycoproteins
23. Histochemical demonstration of side‐chain substituted sialic acid
24. Mucosubstance histochemistry of the normal mucosa and carcinoma of the large intestine. Galactose oxidase‐Schiff reaction and lectin stainings
25. Peanut lectin and anti‐li antibodies reveal structural differences among human gastrointestinal glycoproteins
26. Tumour‐associated and differentiation antigens on the carbohydrate moieties of mucin‐type glycoproteins
27. Alterations in human colonic mucin occurring with cellular differentiation and malignant transformation
28. A cancer‐associated mucin alteration in benign colonic polyps
29. Comparative immunoperoxidase demonstration of T‐antigens in human colorectal carcinoma and morphologically abnormal mucosa
30. O‐linked mucin‐type glycoproteins in normal and malignant colon mucosa: Lack of T‐antigen expression and accumulation of Tn and sialosyl‐Tn antigens in carcinomas
31. Gastrointestinal mucus. Structures and antigenicities of their carbohydrate chains in health and disease
32. Alteration of mucin‐bound carbohydrate moieties in malignant transformation of colonic mucosa
33. Structural variations of blood group A antigens in human normal colon and carcinomas
34. Regional differences in normal and cancer‐associated glycoconjugates of the human colon
35. b in human normal, fetal, and malignant colonic tissue
36. Blood group antigens as markers for normal differentiation and malignant change in human tissues
37. Peanut lectin binding sites in large bowel carcinoma
38. Peanut lectin‐binding sites in polyps of the colon and rectum
39. Cellular localization of PNA binding in colorectal adenomas: Comparison with differentiation, nuclear: cell height ratio and effect of desi‐alylation
40. Hepatic and intestinal expression of human glycosyltransferase
41. The putative link glycopeptide associated with mucus glycoproteins: Composition and properties of preparations from gastrointestinal tracts of several mammals
42. Gastrointestinal mucus: Synthesis, secretion, and function
43. Neutral and acidic species of human intestinal mucin. Evidence for different core peptides
44. Mucin genes and the proteins they encode: Structure, diversity, and regulation
45. Molecular cloning of human intestinal mucin (MUC2) cDNA. Identification of the amino functions and overall sequence similarity to prepro‐von Willebrand factor
46. The human MUC2 intestinal mucin has cysteine‐rich sub‐domains located both upstream and downstream of its central repetitive region
47. MUC‐2 human small intestinal mucin gene structure. Repeated arrays and polymorphism
48. Molecular cloning and expression of human tumour‐associated polymorphic epithelial mucin
49. Molecular cloning and chromosomal localisation of a novel human tracheo‐bronchial mucin cDNA containing tandemly repeated sequences of 48 base pairs
50. Evidence for different human tracheobronchial mucin peptides deduced from nucleotide cDNA sequences
51. Human gastric mucin. Identification of a unique species by expression cloning
52. Molecular cloning, sequence and specificity of expression of the gene encoding the low molecular weight human salivary mucin (MUC7)
53. Degenerate 87‐base‐pair tandem repeats create hydrophilic/hydrophobic alternating domains in human mucin peptides mapped to 11 p15
54. Composition of human colonic mucin. Selective alterations in inflammatory bowel disease
55. Heterogeneity of mucin gene expression in normal and neoplastic tissues
56. Expression of human mucin genes in respiratory, digestive and reproductive tracts ascertained by in situ hybridisation
57. Mucin gene expression in colonic tissues and cell lines
58. Hyperplastic polyps: A cell lineage which both synthesizes and secretes trefoil‐peptides and has phenotypic similarity with the ulcer‐associated cell lineage
59. Detection of the MUC2 apomucin tandem repeat with a mouse monoclonal antibody
60. Mucolysis of the colonic mucus barrier by faecal proteinases: Inhibition by interacting polyacrylate
61. Functional biology of intestinal goblet cells
62. Inhibition of Helicobacter pylori colonisation by sulfated gastric mucin
63. Microbialecologyofthegastrointestinaltract.Annu
64. The mucosa‐associated microflora of the rat intestine: A study of normal distribution and magnesium sulfate induced diarrhoea
65. Colonic mucus in health and disease
66. Roles of endogenous substances and bacteria in colorectal cancer
67. The glycoconjugate content of human faeces and ileostomy effluents
68. Transitional mucosa of the large intestine
69. Value of mucin histochemistry in follow up surveillance of patients with long standing ulcerative colitis
70. Sialomucins and carcinoembryonic antigen in the evolution of colorectal cancer
71. Mucosubstance histochemistry of the normal mucosa and epithelial neoplasms of the large intestine
72. Failure to demonstrate specificity of the morphological and histochemical changes in mucosa adjacent to colonic carcinoma (transitional mucosa)
73. The adenoma‐carcinoma sequence in the colorectum – early appearance of a hierarchy of small intestinal mucin antigen (SIMA) epitopes and correlation with malignant potential
74. Differentiation‐ associated changes in mucin glycoprotein antigenicity in mucosa adjacent to rare gastrointestinal tract tumours of non‐mucosal origin
75. Colorectal goblet cell sialomucin heterogeneity: Its relation to malignant disease
76. Mucin abnormality of colonic mucosa in patients with familial polyposis coli
77. Crypt restricted heterogeneity of goblet cell mucus glycoprotein in histologically normal human colonic mucosa: A potential marker of somatic mutation
78. Racial variation in O‐acetylation of human colonic sialomucins
79. Basis of sialic acid heterogeneity in ulcerative colitis
80. Colorectal goblet cell mucins in familial adenomatous polyposis
81. Mucin abnormality of colonic mucosa in ulcerative colitis associated with carcinoma and/or dysplasia
82. Sialic acid histochemistry and the adenoma‐carcinoma sequence in colorectum
83. Sialic acid and epithelial differentiation in colorectal polyps and cancer – a morphological, mucin and lectin histochemical study
84. Distribution of mono‐, di‐, and tri‐O‐acetylated sialic acids in normal and neoplastic colon
85. Histochemical and morphologic studies of mucosa bordering rectosigmoid carcinomas: Comparisons with normal, diseased, and malignant colonic epithelium
86. Aberrant expression of intestinal mucin antigens associated with colorectal carcinoma defined by a panel of monoclonal antibodies
87. Expression of a novel family of epitopes on small intestinal mucins in colorectal cancers, adjacent and remote mucosa
88. Synthesis of type 2 human blood‐group antigenic determinants. The H, X, and Y haptens and variations of the H type 2 determinant as probes for the combining site of the lectin 1 of Ulex europaeus
89. Histochemical demonstration of sugar residues by lectin and immunocyto‐chemical techniques for blood group antigens in human colon
90. Lectin expression in neoplastic and non‐neoplastic lesions of the rectum
91. Regional distribution of glycoconjugates in normal, transitional and neoplastic human colonic mucosa. A histochemical study using lectins
92. Appearance of Ulex europaeus agglutinin‐1 and Griffonia simplicifolia agglutinin‐1 binding sites on cancer cells in sigmo‐rectal polyps
93. Ulex europaeus agglutinin‐1 binding in hereditary bowel cancer
94. Glycoconjugate with Ulex europaeus agglutinin‐1 ‐binding sites in normal mucosa, adenoma, and carcinoma of the human large bowel
95. Dolichos biflorus agglutinin binding in hereditary bowel cancer
96. Lectin‐binding sites in normal, hyperplastic, adenomatous and carcinomatous human colorectal mucosa
97. Lectin binding patterns in normal and neoplastic colonic mucosa. A study of Dolichos biflorus agglutinin, peanut agglutinin, and wheat germ agglutinin
98. Organized differentiation of tumor cells of villous adenomas of the large intestine
99. Studies on the Thomsen‐Friedenreich antigen in human colon with the lectin Amaranthin. Normal and neoplastic epithelium express only cryptic T antigen
100. b, x, and y blood group antigens in human colonic tumors and normal tissue and in human tumor‐derived cell lines
101. ABH and Lewis blood group expression in colorectal carcinoma
102. Immunohistologic expression of blood‐group antigens in normal human gastrointestinal tract and colonic carcinoma
103. Immunohistochemical localization of Y hapten and the structurally related H type‐2 blood‐group antigen on large‐bowel tumours and normal adult tissues
104. y blood group‐related antigens in human malignant, premalignant, and nonmalignant colonic tissues
105. y) defined by monoclonal antibody AH6 in different locations of colonic epithelia, various histological types of colonic polyps, and adenocarcinomas
106. Expression of a carbohydrate differentiation antigen, stage‐specific embryonic antigen 1, in human colonic adenocarcinoma
107. y related antigen expression in human malignant and nonmalignant colonic tissues
108. x antigens in human colorectal polyps
109. x antigen as defined by monoclonal antibody AM‐3 is a marker of dysplasia in the colonic adenoma‐carcinoma sequence
110. A monoclonal antibody specific for the Thomsen‐Freidenreich cryptic T antigen
111. A method for T‐antigen demonstration by a polyclonal antibody and peanut lectin: Elimination of cross‐reaction with naturally occurring antibodies
112. Comparison of T‐antigen expression in normal, premalignant, and malignant human colonic tissue using lectin and antibody immunohisto‐chemistry
113. Mucin associated Tn and sialosyl‐Tn antigen expression in colorectal polyps
114. Monoclonal antibodies against partially deglycosylated colon cancer mucin that recognize Tn antigen
115. A novel mucin antigen associated with prognosis in colorectal cancer patients
116. Sialic acids XIII: A uridine diphosphate D‐galactose: Mucin galactosyl‐transferase from porcine submaxillary gland
117. Structures of major oligosaccharides from a human rectal adenocarcinoma glycoprotein
118. Monoclonal antibody TKH2 to the cancer‐associated epitope sialosyl Tn shows cross‐reactivity with variants of normal colorectal goblet cell mucin
119. Expression of Tn, sialosyl Tn, and T antigens in human pancreas
120. Expression of sialosyl‐Tn in intestinal type cancer cells of human gastric cancers
121. Mucin synthesis and secretion in various human epithelial cancer cell lines that express the MUC‐1 mucin gene
122. Immune recognition of human colonic‐tumour‐associated MUC‐2 mucins using an anti‐peptide antibody
123. Expression of large intestinal mucin antigen (LIMA) epitopes in the normal and neoplastic gastrointestinal tract
124. Monoclonal antibodies to human colorectal epithelium: Markers for differentiation and tumour characterization
125. Antigen expression in normal and neoplastic colonic mucosa: three Tissuespecific antigens using monoclonal antibodies to isolated colonic glands
126. Gland to gland heterogeneity in histologically normal mucosa of colon cancer patients demonstrated by monoclonal antibodies to tissue‐specific antigens
127. Colorectal polyps in an Australian population. A histological and immunohistochemical study
128. Distribution of O‐acetylated sialomucin in the normal and diseased gastrointestinal tract shown by a new monoclonal antibody
129. Human colonic sulfomucin identified by a specific monoclonal antibody
130. cis‐Golgi resident proteins and O‐glycans are abnormally compartmentalized in the RER of colon cancer cells
131. Dysplasia in colorectal adenomas related to the presence of O‐acetylated sialic mucin and to morphometric measurements
132. Cancer‐associated alterations of blood group antigen expression in human colorectal polyps
133. Altered glycosylation of the MUC‐1 protein core contributes to the colon carcinoma‐associated increase of mucin‐bound sialyl‐Lewis expression
134. Binding of Ulex europaeus agglutinin‐1 in polyposis coli: Comparative study with solitary adenoma in the sigmoid colon and rectum
135. Lectin staining of neoplastic and normal background colorectal mucosa in nonpolyposis and polyposis patients
136. Abnormalities of lectin histochemistry in familial polyposis coli and hereditary nonpolyposis colorectal cancer
137. Evolution of hereditary bowel cancer
138. y, A, B, H)
139. Search for a specific marker of mucosal dysplasia in chronic ulcerative colitis
140. The role of mucin in colon‐cancer metastasis
141. Metastatic potential of colon carcinoma
142. Lectin‐histochemical studies on the process of liver metastasis of mouse colon carcinoma (colon 26) cells